Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion

J N Rao1, L Li, B L Bass

  • 1Department of Surgery, University of Maryland School of Medicine and Baltimore Veterans Affairs Medical Center, Baltimore, Maryland 21201, USA.

Insights

Inhibiting polyamine synthesis with DFMO increases intestinal cell sensitivity to TGF-beta by upregulating TGF-beta type I receptor (TGF-betaRI) expression. This enhanced TGF-betaRI signaling mediates the growth inhibition response.

Area of Science:

  • Cell biology
  • Molecular biology
  • Gastroenterology

Background:

  • Polyamines are crucial for cell growth and function.
  • Inhibition of polyamine biosynthesis enhances intestinal epithelial cell sensitivity to transforming growth factor-beta (TGF-beta).

Purpose of the Study:

  • To investigate the role of TGF-beta receptor gene expression in polyamine depletion-induced sensitivity to TGF-beta.
  • To determine if TGF-beta type I receptor (TGF-betaRI) expression is involved in this sensitization process.

Main Methods:

  • Utilized the IEC-6 rat intestinal crypt cell line.
  • Administered alpha-difluoromethylornithine (DFMO) to deplete cellular polyamines.
  • Assessed TGF-beta receptor mRNA and protein levels via quantitative methods.
  • Evaluated cell growth inhibition in response to TGF-beta, somatostatin, and laminin.

Main Results:

  • DFMO treatment depleted cellular polyamines (putrescine, spermidine, spermine).
  • Polyamine depletion significantly increased TGF-beta type I receptor (TGF-betaRI) mRNA and protein levels, but not TGF-beta type II receptor.
  • Increased TGF-betaRI expression correlated with heightened sensitivity to TGF-beta-induced growth inhibition.
  • Retinoic acid, which decreased TGF-betaRI expression, blocked the enhanced sensitivity in polyamine-deficient cells.

Conclusions:

  • Depletion of cellular polyamines by DFMO leads to increased expression of the TGF-betaRI gene.
  • Elevated TGF-betaRI expression is a key mechanism mediating the sensitization of intestinal epithelial cells to TGF-beta-induced growth inhibition following polyamine depletion.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...